Ability Biotherapeutics
Developing innovative targeted immuno therapeutics to addressing unmet medical needs for cancer and autoimmune diseases
25 employees · est. 2023 · Montreal, Canada
Ablexis, LLC
A superior, next generation transgenic platform.
1 employees · est. 2009 · San Diego, United States
Ablexis, LLC is the older company (2023 vs 2009); Ability Biotherapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Ability Biotherapeutics | Ablexis, LLC |
|---|---|---|
| Founded | ||
| Founded | 2023 | 2009 older |
| Headquarters | ||
| Headquarters | Montreal, Canada | San Diego, United States |
| Employees | ||
| Employees | 25 larger | 1 |
| Industry | ||
| Industry | Biotechnology, Life Sciences | Biotechnology, Health Care, Medical Devices |
| Funding Stage | ||
| Funding Stage | Seed | Series A |
| Total Funding | ||
| Total Funding | $30.00M | $12.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 1 |
| Services | ||
| Services | Development of precision therapies, Immune cell modulating biotherapeutics, Antibody discovery and engineering, Product candidates pipeline | Not tracked yet |
| Target Customers | ||
| Target Customers | Biopharmaceutical companies, Research institutions, Healthcare providers, Patients with inflammatory diseases, Cancer patients | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Targeted Immunotherapy, Cancer Treatment, Autoimmune Diseases, Biotherapeutics, Antibody Development, AI-Driven Drug Discovery, AbiLeap Discovery Engine, Multispecific Antibodies, Human IgG Antibodies, Immune Modulating Therapies, Antigen-Antibody Interactions, Logic-Gated Therapeutics, Cellular Microenvironment Response, AI/ML In Biotech, Biotech Innovation | Transgenic Platform, Antibody Discovery, Pharmaceuticals, Biopharmaceuticals, Monoclonal Antibodies, Drug Discovery, Therapeutic Antibodies, Biotech, Antibody Engineering, Protein Sciences |
| Website | ||
| Website | ability.bio | ablexis.com |
About Ability Biotherapeutics
Ability Biotherapeutics is an innovative company established in 2023 and headquartered in Canada. Operating within the Biotechnology and Life Sciences industries, the company's slogan captures its groundbreaking approach: "Developing innovative targeted immuno therapeutics to address unmet medical n...
About Ablexis, LLC
Ablexis, LLC is a biotechnology startup that offers the AlivaMab® Mouse platform, a suite of transgenic mouse strains designed for human therapeutic antibody discovery. The platform is tailored for various applications across antibody drug discovery, including the development of highest quality IgGs...
We will tell you when either one moves
BounceWatch watches Ability Biotherapeutics and Ablexis, LLC for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Ability Biotherapeutic... and Ablexis, LLC — by email.
Frequently Asked Questions
Compare Ability Biotherapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Ability Biotherapeutics on 15 Jun 2026, and Ablexis, LLC on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.